Stephen Resch, MPH, PhD, is a Lecturer on Health Decision Science in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health. Dr. Resch’s research focuses on advancing the use of decision analytic approaches in health policy making and health program management. He holds an MPH from Yale University and a PhD from Harvard University.
Constructs decision analytic models, explores costing methods, employs computer simulation to predict benefits, costs and social impacts of policy options.
Works closely with decision makers, global health organizations and government officials across a broad range of public health topics in a variety of settings.
Teaches a core course on economic evaluation in the decision science curriculum at the School of Public Health, advises and mentors students and trainees.
Toscano CM, Jauregui B, Janusz CB, Sinha A, Clark AD, Sanderson C, Resch S, Ruiz Matus C, Andrus JK; ProVac Network of Centers of Excellence. Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac experience. Vaccine. 2013 Jul 2;31 Suppl 3:C12-8. PubMed PMID:23777685.
Enden T, Resch S, White C, Wik HS, Kløw NE, Sandset PM. Cost-Effectiveness of Additional Catheter-Directed Thrombolysis for Deep Vein Thrombosis. Journal of Thrombosis and Haemostasis. 2013 In press.
Chen S, Toy M, Yeh J, Wang JD, Resch S. Cost-effectiveness of Adding Maternal Screening and Neonatal Immunoglobulin to Universal Hepatitis B Vaccination. Pediatrics. 2013. In press.
Jit M, Levin C, Brison M, Levin A, Resch S, Berkhof J, Kim J, Hutubessy R. Economic analyses to support decisions about HPV vaccination in low and middle income countries: a consensus report and guide for analysts. BMC Medicine 2013, 11:23
Spaulding AC, Pinkerton SD, Superak H, Cunningham MJ, Resch S, Jordan AO, Yang Z. Cost Analysis of Enhancing Linkages to HIV Care Following Jail: A Cost-Effective Intervention. AIDS Behav. In Press, [Epub ahead of print 2012 Nov 9].
Kimmel AD, Resch SC, Anglaret X, Daniels N, Goldie SJ, Danel C, Wong AY, Freedberg KA, Weinstein MC. Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability. Cost Eff Resour Alloc. 2012 Sep 19;10(1):12. PMCID. PMC3502124.
Erim D, Resch S, Goldie SJ. Assessing health and economic outcomes of interventions to reduce pregnancy-related mortality in Nigeria. BMC Public Health. 2012;12:786.
Erim DO, Kolapo UM & Resch SC. A rapid assessment of the availability and use of obstetric care in Nigerian healthcare facilities. PLOS One. 2012 Jun; 7(6): e39555. Cited in PubMed; PMID: 22745784. Publication Status: Published.
Lin MM, Goldsmith JD, Resch SC, Deangelis JP, Ramappa AJ. Histologic Examinations of Arthroplasty Specimens are not Cost-effective: A Retrospective Cohort Study. Clin Orthop Relat Res. 2012 May; 470(5):1452-60.
Resch S, Korenromp E, Stover J, Blakley M, Krubiner C, et al. 2011 Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries. PLoSONE. 2011; 6(10): e25310. PMCID: PMC3187775.
Lin JS, Resch SC, Brimmer DJ, Johnson A, Kennedy S, Burstein N, Simon CJ. The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs. Cost Effectiveness and Resource Allocation 2011, 9:1 PMCID: PMC3033815.
Jauregui B, Sinha A, Clark AD, Bolanos BM, Resch S, Toscano CM, Matus CR, Andrus JK. Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: Lessons learned by PAHO’s ProVac Initiative. Vaccine. 2010 Dec 7. PMID: 21144916.
Semel ME, Resch S, Haynes AB, Funk LM, Bader A, Berry WR, Weiser TG, Gawande AA. Adopting a surgical safety checklist could save money and improve the quality of care in U.S. hospitals. Health Affairs 2010 Sep;29(9):1593-9. PMCID: PMC3069616.
Darst JR, Newburger JW, Resch S, Rathod RH, Lock JE. Deciding without data. Congenit Heart Dis. 2010 Jul;5(4):339-42. PMID: 20653700.
Regenbogen SE, Greenberg CC, Resch SC, Kollengode A, Cima RR, Zinner MJ, Gawande AA. Prevention of retained surgical sponges: a decision-analytic model predicting relative cost-effectiveness. Surgery 2009; 145(5):527-35. PMCID: PMC2725304.
Resch SC, Salomon JA, Murray M, Weinstein MC. Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Medicine 2006; 3(7):e241. PMCID: PMC1483913.
Salomon J, Lloyd-Smith J, Getz W, Resch S, Sánchez M, Porco T, Borgdorff M. Prospects for advancing tuberculosis control efforts through novel therapies. PLoS Medicine 2006;3(8):e273. PMID: 16866578
READ MORE ABOUT DR. RESCH
Stephen Resch, MPH, PhD, is a Lecturer on Health Decision Science in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health. Dr. Resch’s research focuses on advancing the use of decision analytic approaches in health policymaking and health program management. Dr. Resch is a generalist who often works closely with global health organizations and government officials across a broad range of public health topics and settings. Internationally, his work in has addressed policy issues related to resource requirements, financial sustainability, and economic efficiency of health programs to treat or prevent of HIV, TB, malaria, and hepatitis, as well as programs to improve maternal and neonatal survival in childbirth, and vaccination. Domestically, Dr. Resch has worked on evaluation of obesity prevention interventions, HIV testing and linkage to care for incarcerated populations, and evaluation of dental interventions to prevent tooth decay in high-risk children. His work often involves constructing decision analytic models and employing computer simulation to predict health benefits, costs and other social impacts of alternative policy options. His core motivation is to aid decision makers in identifying decision criteria consistent with their goals and providing evidence that clarifies relevant constraints, trade-offs and uncertainties. He holds and MPH from Yale University and a PhD from Harvard University. He teaches a course on economic evaluation in the decision science curriculum at the Harvard Chan School.